---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-002314"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2024-01-09T23:59:59+00:00"
generated_at: "2026-06-07T01:27:21.396879+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma extends stock repurchase program up to $1M through March 31, 2024

## Summary
- Board extended stock repurchase program through March 31, 2024.
- Authorization remains at up to $1 million of common stock.
- Extension approved on January 9, 2024.

## SEC filing metadata
- accession: 0001213900-24-002314
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2024-01-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390024002314/0001213900-24-002314-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390024002314/ea191279-8k_silopharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-002314
- JSON: https://secwatch.observer/filing/0001213900-24-002314.json
- Plain text: https://secwatch.observer/filing/0001213900-24-002314.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.